The global hemodialysis market size was valued at USD 74.14 billion in 2021, growing at a CAGR of 6.9% during the forecast period 2022-28. Hemodialysis is a procedure that removes waste from the blood, such as urea, restores electrolyte balance in the blood, and removes excess fluid from the body using an artificial membrane. When kidney function falls below 10% to 15%, it is no longer capable of filtering blood. Toxins and extra fluid buildup in the body as a result of this. Toxins are removed through hemodialysis. For patients with end-stage renal illness, it is a successful therapy. Hemodialysis comes in a variety of forms. Hemodialysis at a hospital or dialysis facility is called in-center hemodialysis. Three times a week, in the assistance of a technician, home hemodialysis is performed. Five to seven days a week, daily home hemodialysis is performed. In six to eight hours, nocturnal home hemodialysis is completed. Unfortunately, the global outbreak of COVID-19 and the lockdown scenario in certain countries created some problems on the market, as hospitals and clinics were forced to suspend services in order to stop the spread of the COVID-19 virus.

View Detailed Report Description 

An increase in the frequency of hypertension and diabetes, as well as a rise in the number of patients with end-stage renal disease and the elderly population, are the main drivers of market development. One of the most important risk factors for chronic renal disease is age. Aging has an impact on the kidney, causing structural and functional changes that impair renal function. Furthermore, the elderly is more susceptible to chronic conditions such as diabetes and hypertension, which are major causes of renal damage. As a result, a significant growth driver for the worldwide hemodialysis market is the growing global occurrence of hypertension and diabetes. During the projection period, the market will be restrained by many product recalls, a growth in kidney transplantation, and the risks and issues associated with dialysis.

The global hemodialysis market segmentation:
1) By Type: Conventional, Daily, Nocturnal.
2) By Product: Equipment, Consumable, Drug, catheters.
3) By Services: In-center dialysis, Home dialysis.
4) By End User: Hospitals, Dialysis Centers

Owing to the increased prevalence of renal illnesses, the rising number of diabetic and hypertension patients, and new technologies in the healthcare business, North America is expected to dominate the market. Asia Pacific is expected to grow at the highest CAGR among developing markets throughout the projected period.

Request sample report   

Some of the major key players in the hemodialysis market, which includes Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (US), Baxter International, Inc. (US), Cantel Medical Corporation (US), NIKKISO CO., LTD (Japan), Dialife Group (Switzerland), Braun Melsungen AG (Germany), Diaverum Healthcare Partners (Germany), Asahi Kasei Corporation (Japan), Medtronic Plc (Ireland), NxStage Medical, Inc. (US).

About Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthsusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights
 | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: | D U N S® Number: 852781747